"Cancer Treatment Centers of America® (CTCA), Phoenix, is a comprehensive cancer care and research center located west of downtown Phoenix in Goodyear, Arizona. CTCA® is dedicated to tailoring a combination of cancer treatments to the needs of each individual patient. Comprehensive cancer services, from advanced genomic testing to clinical trials and evidence-informed supportive therapies, are delivered by a team of experts, all under one roof. Our oncologists offer a level of expertise that comes from working with cancer patients every day to deliver personalized medicine using today's scientific advances. We treat patients with all types and stages of cancer, at any point in their journey. Cancer treatment is our specialty."

During the past decade, Southeastern Regional Medical Center - CTCA - PPDS conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeastern Regional Medical Center - CTCA - PPDS" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Southeastern Regional Medical Center - CTCA - PPDS" are "Leukemia, Myeloid, Acute" (1 trials), "Leukemia, Myelomonocytic, Chronic" (1 trials), "Metastatic Renal Cell Carcinoma" (1 trials), "Myelodysplastic Syndrome" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Southeastern Regional Medical Center - CTCA - PPDS" in a lesser frequency.

Most popular intervention types in "Southeastern Regional Medical Center - CTCA - PPDS" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (1 trials), "Pevonedistat" (1 trials), "bempegaldesleukin" (1 trials), "cabozantinib" (1 trials) and "nivolumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Regional Medical Center - CTCA - PPDS" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Southeastern Regional Medical Center - CTCA - PPDS". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Southeastern Regional Medical Center - CTCA - PPDS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Regional Medical Center - CTCA - PPDS, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".